Announce Date | 12/05/2024 |
EPS Normalized Actual | $0.16 In Line |
EPS GAAP Actual | $0.16 In Line |
Revenue Actual | $0.122942B |
Revenue Surprise | Beat by $122.942M |
Announce Date | 07/30/2025 (Pre-Market) |
EPS Normalized Estimate | $0.172 |
EPS GAAP Estimate | $0.172 |
Revenue Estimate | $0.114237916B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Jul 2028 | 0.87 | 12.75 | 0.80387 | 0.99304 | 0 |
Jul 2027 | 0.8 | 13.86 | 0.73919 | 0.91314 | 0 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ4 2024 (Oct 2024) | 0.0759 | -1.46147 | 0.122942B | -22.96% | -102.27M |
FQ3 2024 (Jul 2024) | 0.0768 | 0.0768 | 0.107395B | -34.93% | 107.4M |
FQ4 2019 (Oct 2019) | 0 | 0 | 0.072704B | 100% | 72.7M |
FQ2 2024 (Apr 2024) | 0.12 | 0.12 | 0.092532B | 100% | 92.53M |
FQ1 2024 (Jan 2024) | 0.14 | 0.14 | 0.147772B | 29.97% | 147.77M |
FQ4 2023 (Oct 2023) | 0.13 | 0.13 | 0.151165B | 28.44% | 151.17M |
FQ3 2023 (Jul 2023) | 0.15 | 0.15 | 0.144908B | 46.17% | 144.91M |
FQ1 2023 (Jan 2023) | 0.13 | 0.13 | 0.103488B | 100% | 103.49M |
FQ4 Announce Date
07/30/2025 (Pre-Market)
Consensus EPS Estimates
0.172
Consensus Revenue Estimates
0.114237916B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ2 2027 (Apr 2027) | 0 | -- | 0 | 0 | 0 |
FQ1 2027 (Jan 2027) | 0 | -- | 0 | 0 | 0 |
FQ4 2026 (Oct 2026) | 0 | -- | 0 | 0 | 1 |
FQ3 2026 (Jul 2026) | 0 | -- | 0 | 0 | 1 |
FQ2 2026 (Apr 2026) | 0 | -- | 0 | 0 | 1 |
FQ1 2026 (Jan 2026) | 0 | -- | 0 | 0 | 2 |
FQ4 2025 (Oct 2025) | 0 | -INF | 0 | 0 | 2 |
FQ3 2025 (Jul 2025) | 0.172 | 55.35 | 0.15925 | 0.19222 | 2 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ2 2027 (Apr 2027) | 0.13B | -- | 0.13B | 0.13B | 1 |
FQ1 2027 (Jan 2027) | 0.15B | -- | 0.14B | 0.15B | 1 |
FQ4 2026 (Oct 2026) | 0.14B | -- | 0.14B | 0.14B | 1 |
FQ3 2026 (Jul 2026) | 0.11B | -- | 0.11B | 0.12B | 2 |
FQ2 2026 (Apr 2026) | 0.11B | -- | 0.11B | 0.12B | 2 |
FQ1 2026 (Jan 2026) | 0.14B | -- | 0.12B | 0.15B | 4 |
FQ4 2025 (Oct 2025) | 0.12B | 0.28 | 0.12B | 0.13B | 1 |
FQ3 2025 (Jul 2025) | 0.11B | 5.99 | 0.11B | 0.12B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
6
EPS # of Misses
1
EPS # of in-lines
1
Revenue # of Beats
7
Revenue # of Misses
1
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ4 2024 (Oct 2024) | 1.53737 | 0.0759 | -1.46147 | -1925.52% |
FQ3 2024 (Jul 2024) | 0.0768 | 0.0768 | 100% | |
FQ4 2019 (Oct 2019) | 0 | 0 | NAN% | |
FQ2 2024 (Apr 2024) | 0.12 | 0.12 | 100% | |
FQ1 2024 (Jan 2024) | 0.14 | 0.14 | 100% | |
FQ4 2023 (Oct 2023) | 0.13 | 0.13 | 100% | |
FQ3 2023 (Jul 2023) | 0.15 | 0.15 | 100% | |
FQ1 2023 (Jan 2023) | 0.13 | 0.13 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ4 2024 (Oct 2024) | $0.23B | $0.12B | $-102.27M | -83.19% |
FQ3 2024 (Jul 2024) | $0B | $0.11B | $107.4M | 100% |
FQ4 2019 (Oct 2019) | $0B | $0.07B | $72.7M | 100% |
FQ2 2024 (Apr 2024) | $0B | $0.09B | $92.53M | 100% |
FQ1 2024 (Jan 2024) | $0B | $0.15B | $147.77M | 100% |
FQ4 2023 (Oct 2023) | $0B | $0.15B | $151.17M | 100% |
FQ3 2023 (Jul 2023) | $0B | $0.14B | $144.91M | 100% |
FQ1 2023 (Jan 2023) | $0B | $0.1B | $103.49M | 100% |